Table 6.
Distribution of psychotropic medications in the study population (n = 1015).
| Drugs | n | % |
|---|---|---|
| Monotherapy | ||
| Long-acting psychostimulants | 298 | 29.3 |
| Short-acting psychostimulants | 49 | 5.0 |
| Atomoxetine | 92 | 9.0 |
| Antidepressants | 162 | 16.0 |
| Antipsychotics | 158 | 24.0 |
| Antihistaminics | 27 | 2.6 |
| Mood stabilizers | 7 | 0.7 |
| Combination therapy | ||
| Psychostimulant + Antipsychotic | 122 | 12.0 |
| Antipsychotic +Atomoxetine | 45 | 4.4 |
| Long acting + short acting psychostimulant | 23 | 2.3 |
| Psychostimulant + Atomoxetine | 15 | 1.5 |
| Antipsychotic + Mood stabilizer | 7 | 0.7 |
| Antipsychotic + Antidepressant | 5 | 0.5 |
| Psychostimulant + Antipsychotic + Atomoxetine | 23 | 2.3 |
| Psychostimulant + Antipsychotic + Mood stabilizer | 10 | 1.0 |
| Psychostimulant + Antipsychotic + Atomoxetine | 9 | 0.9 |
| Antipsychotic + Antidepressant + Mood stabilizer | 6 | 0.6 |
| Antipsychotic + Atomoxetine + Mood stabilizer | 9 | 0.9 |